Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.
Автор: Life Science Connect
Загружено: 2025-08-12
Просмотров: 560
Описание:
On this episode of Better Biopharma, Interius BioTherapeutics’ Sianny Christanti and Babu Medi, Ph.D., explain how the company is re-engineering a lentiviral vector to enable INT2104, its off-the-shelf, in vivo CAR T-cell therapy. They discuss the vector's design and its manufacturability, as well as the analytical and regulatory challenges of bringing this first-in-human therapy to the clinic.
Follow Tyler Menichiello on LinkedIn: / tmenichiello
Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/
Subscribe to our newsletters: https://www.bioprocessonline.com/user...
--
Subscribe to the podcast!
Apple - https://podcasts.apple.com/us/podcast...
Spotify - https://open.spotify.com/show/3dvQdIL...
YouTube - • Better Biopharma
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
